Imperial College London


Faculty of MedicineDepartment of Medicine

Wynn Chair in Human Metabolism (Clinical)



+44 (0)20 3313 1593nick.oliver




7S7aCommonwealth BuildingHammersmith Campus





Nick is the Wynn professor of human metabolism and is a consultant diabetes and endocrinology Imperial College Healthcare NHS Trust. His clinical and academic interest is type 1 diabetes and the application of technology.



Srivanichakorn W, Godsland IF, Washirasaksiri C, et al., 2018, Cardiometabolic risk factors in Thai individuals with prediabetes treated in a high-risk, prevention clinic: Unexpected relationship between high-density lipoprotein cholesterol and glycemia in men., J Diabetes Investig

Loh WJ, Johnston DG, Oliver N, et al., 2018, Skinfold thickness measurements and mortality in white males during 27.7 years of follow-up, International Journal of Obesity, Vol:42, ISSN:0307-0565, Pages:1939-1945

Reddy M, Jugnee N, Anantharaja S, et al., 2018, Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study, Diabetes Technology & Therapeutics, Vol:20, ISSN:1520-9156, Pages:751-757

Perera R, Oliver N, Wilmot E, et al., 2018, Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England, Diabetic Medicine, Vol:35, ISSN:0742-3071, Pages:1617-1618

Oliver N, Reddy M, 2018, Reply to Seibold and Schlaeger: Comparison of continuous and flash glucose monitoring in Type 1 diabetes: methodological inconsistency precludes hypoglycaemia conclusions, Diabetic Medicine, Vol:35, ISSN:0742-3071, Pages:1619-1620

More Publications